<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="21208">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02830802</url>
  </required_header>
  <id_info>
    <org_study_id>gerodont_3: Sage Trial</org_study_id>
    <nct_id>NCT02830802</nct_id>
  </id_info>
  <brief_title>Clinical Trial for Evaluating Sage-Based Mouthrinse</brief_title>
  <official_title>Randomized Controlled Clinical Trial for Evaluating a Sage-based Mouthrinse in Regard to Its Anti-inflammatory Potential in Elderly Patients Which Are Dependent in Their ADLs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bern</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>WALA Heilmittel GmbH</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Bern</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to evaluate a sage-based mouthrinse (Dr. Hauschka Med, Mundspülung
      Salbei) whether it is less or equal effective in alleviating inflammatory signs of
      intra-oral mucosa and gingiva than an water/alcohol-based taste adjusted placebo in patients
      dependent on ADL.

      Randomization in treatment A (mouthwash with active agent, n=24) or treatment B (placebo
      mouthwash, n=24) Supervised use of mouthwash A or mouthwash B over 6 weeks 1x/day additional
      to habitual oral hygiene protocol.

      The main outcome parameter will be Sulcus Bleeding Index SBI.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A sage-based mouthrinse based on an extract from Salvia officinalis in a composition with
      extracts from Althaea Officinalis, Aesculus Hippocatanum Bark and essential oils might
      comprise an alternative to conventional antimicrobial mouthrinses, which might exhibit
      important side effects. Thus the aim of the current study is to test the null-hypothesis H0:

      A sage-based mouthrinse (Dr. Hauschka Med, Mundspülung Salbei, WALA Heilmittel GmbH,
      Dorfstraße 1, 73087 Bad Boll/Eckwälden, Germany) is less or equal effective in alleviating
      inflammatory signs of intra-oral mucosa and gingiva than an water/alcohol-based taste
      adjusted placebo.

      The placebo and the sage-based mouthrinse will be manufactured according to
      EU-Kosmetik-Verordnung 1223/2009 and provided by WALA Heilmittel GmbH, Dorfstraße 1, 73087
      Bad Boll/Eckwälden, Germany together with the necessary safety documentation. The placebo
      will be an alcohol/ water based solution with a similar taste to the tested mouthrinse.

      The main outcome parameter will be Sulcus Bleeding Index SBI. Among others, the main
      secondary outcome parameters will be Oral Health Related Quality of Life as assessed with
      the OHIP-14 G questionnaire, the Xerostomia inventory and a Tooth staining index.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>October 2016</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sulcus Bleeding Index</measure>
    <time_frame>six weeks</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Stomal Bleeding</condition>
  <condition>Stomatitis, Denture</condition>
  <condition>Tooth Staining</condition>
  <condition>Satisfaction</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Active Agent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dr. Hauschka Med Mundspüllösung Salbei / cosmetics</intervention_name>
    <description>Supervised use over 6 weeks 1x/day additional to habitual oral hygiene protocol.
For an application fill the closure cap with the mouthwash. Rinse the mouth vigorously for 30 seconds, for easier timekeeping use the hourglass. Then spit out the mouthwash, do not rinse.</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Supervised use over 6 weeks 1x/day additional to habitual oral hygiene protocol.
For an application fill the closure cap with the mouthwash.</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to give informed consent, i.e. no legal guardian appointed

          -  Willing to participate

          -  Depended on their ADLs (IADL)(24)

          -  Sulcus Bleeding Index (SBI) &gt; 50%

        Exclusion Criteria:

          -  Allergy to one of the components

          -  Edentulous

          -  Alcohol dependency

          -  Prescription of antibiotics and/ or immunosuppressives (e.g. glucocorticoids)
             Anti-inflammatory mouthrinse -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Schimmel, Prof.</last_name>
    <role>Study Chair</role>
    <affiliation>University of Bern</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Martin Schimmel, Prof.</last_name>
    <phone>+4131 6322597</phone>
    <email>martin.schimmel@zmk.unibe.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hendrik Juenger, Dr.</last_name>
    <phone>+4131 7477025</phone>
  </overall_contact_backup>
  <verification_date>July 2016</verification_date>
  <lastchanged_date>July 8, 2016</lastchanged_date>
  <firstreceived_date>July 1, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stomatitis</mesh_term>
    <mesh_term>Tooth Discoloration</mesh_term>
    <mesh_term>Stomatitis, Denture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
